Synmosa Biopharma Corporation (4114.TWO)

TWD 33.45

(0.0%)

Market Cap (In TWD)

13.88 Billion

Revenue (In TWD)

5.14 Billion

Net Income (In TWD)

594.83 Million

Avg. Volume

1.27 Million

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
32.25-38.35
PE
-
EPS
-
Beta Value
0.282
ISIN
TW0004114004
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Chih-Hui Lin
Employee Count
-
Website
https://www.synmosa.com.tw
Ipo Date
2007-12-31
Details
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.